These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Developing attributes and attribute-levels for a discrete choice experiment on micro health insurance in rural Malawi. Abiiro GA, Leppert G, Mbera GB, Robyn PJ, De Allegri M. BMC Health Serv Res; 2014 May 22; 14():235. PubMed ID: 24884920 [Abstract] [Full Text] [Related]
44. Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. van der Straten A, Stadler J, Montgomery E, Hartmann M, Magazi B, Mathebula F, Schwartz K, Laborde N, Soto-Torres L. PLoS One; 2014 May 22; 9(2):e89118. PubMed ID: 24586534 [Abstract] [Full Text] [Related]
49. Strategies to Implement Pre-exposure Prophylaxis with Men Who Have Sex with Men in Ukraine. Dubov A, Fraenkel L, Yorick R, Ogunbajo A, Altice FL. AIDS Behav; 2018 Apr 22; 22(4):1100-1112. PubMed ID: 29214409 [Abstract] [Full Text] [Related]
50. The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa. Quaife M, Terris-Prestholt F, Eakle R, Cabrera Escobar MA, Kilbourne-Brook M, Mvundura M, Meyer-Rath G, Delany-Moretlwe S, Vickerman P. J Int AIDS Soc; 2018 Mar 22; 21(3):. PubMed ID: 29537654 [Abstract] [Full Text] [Related]
51. Delivering PrEP to Young Women in a Low-Income Setting in South Africa: Lessons for Providing Both Convenience and Support. Cassidy T, Ntuli N, Kilani C, Malabi N, Rorwana B, Mutseyekwa T, O'Connell R, Steele SJ, Ndlovu Z, Ellman T, de Azevedo V, Pfaff C, Nelson A, Duran LT. AIDS Behav; 2022 Jan 22; 26(1):147-159. PubMed ID: 34259963 [Abstract] [Full Text] [Related]
53. Understanding user perspectives of and preferences for oral PrEP for HIV prevention in the context of intervention scale-up: a synthesis of evidence from sub-Saharan Africa. Eakle R, Weatherburn P, Bourne A. J Int AIDS Soc; 2019 Jul 22; 22 Suppl 4(Suppl Suppl 4):e25306. PubMed ID: 31328429 [Abstract] [Full Text] [Related]
57. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya. Patel RC, Stanford-Moore G, Odoyo J, Pyra M, Wakhungu I, Anand K, Bukusi EA, Baeten JM, Brown JM. J Int AIDS Soc; 2016 Jul 22; 19(1):21134. PubMed ID: 27964776 [Abstract] [Full Text] [Related]
58. Early pre-exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South Africa. Joseph Davey DL, Mvududu R, Mashele N, Lesosky M, Khadka N, Bekker LG, Gorbach P, Coates TJ, Myer L. J Int AIDS Soc; 2022 Feb 22; 25(2):e25866. PubMed ID: 35138678 [Abstract] [Full Text] [Related]
59. Preferences regarding emerging HIV prevention technologies among Toronto men who have sex with men: a discrete choice experiment. Tan DHS, Rana J, Tengra Z, Hart TA, Wilton J, Bayoumi AM. Sci Rep; 2021 Nov 15; 11(1):22252. PubMed ID: 34782691 [Abstract] [Full Text] [Related]